Kush Parmar's Net Worth
$183 Million
Who is Kush Parmar?
Kush Parmar has an estimated net worth of $183 Million. This is based on reported shares across multiple companies, which include Enliven Therapeutics, Inc., Skye Bioscience, Inc., CinCor Pharma, Inc., Entrada Therapeutics, Inc., Vor Biopharma Inc., Rallybio Corp, ARVINAS, INC., 5:01 Acquisition Corp., IMPEL NEUROPHARMA INC, scPharmaceuticals Inc., Cabaletta Bio, Inc., Akouos, Inc., Homology Medicines, Inc., Audentes Therapeutics, Inc., and Aprea Therapeutics, Inc..
SEC CIK
Kush Parmar's CIK is 0001664281
Past Insider Trading and Trends
2021 was Kush Parmar's most active year for acquiring shares with 26 total transactions. Kush Parmar's most active month to acquire stocks was the month of May. 2021 was Kush Parmar's most active year for disposing of shares, totalling 26 transactions. Kush Parmar's most active month to dispose stocks was the month of October. 2022 saw Kush Parmar paying a total of $25,520,000.00 for 5,019,687 shares, this is the most they've acquired in one year. In 2019 Kush Parmar cashed out on 7,945,433 shares for a total of $13,204,050.00, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Skye Bioscience, Inc. (SKYE) Snapshot price: $4.98
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
| +5.66% | 450K |
$10.00 | $4,500,000.00 | 8.39M |
Mar 13
| |||
Form 4
| +190.18% | 5.21M |
$2.31 | $12,026,030.94 | 7.94M |
Jan 31
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
IMPEL NEUROPHARMA INC (IMPL) Snapshot price: $0.05
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
|
∞
| 2.88M |
$14.25 | $8,625,000.00 | 2.88M |
Apr 27
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 22
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
Cabaletta Bio, Inc. (CABA) Snapshot price: $23.79
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
| -12.50% | -295.00K |
$13.00 | -$3,835,000.00 | 2.06M |
Nov 1
| |||
Form 4
| -23.90% | -625.00K |
$9.70 | -$6,062,500.00 | 1.99M |
Sep 7
| |||
Form 4
| -6.01% | -387.00K |
$13.00 | -$5,031,000.00 | 6.05M |
Jan 8 - Jan 12
| |||
Form 4
| -8.12% | -298.00K |
$14.75 | -$4,395,500.00 | 3.37M |
Dec 10
| |||
Form 4
|
∞
| 3.67M |
$11.00 | $4,999,995.00 | 3.67M |
Oct 29
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
Aprea Therapeutics, Inc. (APRE) Snapshot price: $6.713
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
| -55.82% | -175.00K |
$25.30 | -$4,427,500.00 | 138.5K |
Oct 5
| |||
Form 4
| -5.95% | -140.00K |
$33.30 | -$4,662,000.00 | 2.21M |
Jun 16
| |||
Form 4
| -10.82% | -245.00K |
$28.75 | -$7,044,411.50 | 2.02M |
Jun 11
| |||
Form 4
| -10.12% | -255.00K |
$35.15 | -$8,963,250.00 | 2.26M |
May 19
| |||
Form 4
| +140.66% | 2.84M |
$15.00 | $4,999,995.00 | 4.86M |
Oct 7
| |||
No matching records found |
Enliven Therapeutics, Inc. (ELVN) Snapshot price: $15.35
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
| -17.70% | -825.00K |
$14.90 | -$12,292,500.00 | 3.84M |
Feb 14
| |||
Form 4
| -9.69% | -500.00K |
$15.00 | -$7,500,000.00 | 4.66M |
Jan 31
| |||
Form 4
| -3.69% | -197.50K |
$15.00 | -$2,962,500.00 | 5.16M |
Sep 26
| |||
Form 4
| -7.59% | -440.00K |
$16.00 | -$7,040,000.00 | 5.36M |
Aug 24
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |